Ryoichi Murata

Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation

H Takamatsu, Naoki Takezako, Jianbiao Zheng et al. · Annals of Oncology · 2017 · 48 citations · Full text

Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry

Hiroyuki Takamatsu, Takeshi Yoroidaka, Momoko Fujisawa et al. · International Journal of Hematology · 2019 · 26 citations

Hematological Malignancy, Srl 8-Color Single-tube, Medicine +14

Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease

Masaki Yamaguchi, Kaoko Sakai, Ryoichi Murata et al. · Bone Marrow Transplantation · 2002 · 23 citations

Cell Therapy, Transplantation, Marrow Transplantation +10

Eight‐color multiparameter flow cytometry (EuroFlow‐NGF) is as sensitive as next‐generation sequencing in detecting minimal/measurable residual disease in autografts of patients with multiple myeloma

Ryota Urushihara, Naoki Takezako, Takeshi Yoroidaka et al. · eJHaem · 2023 · 11 citations · Full text